Integrative transcriptomic analysis revealed the roles and prognostic value of ion channels in hypertrophic

Shaohua Li1, Jingqi Xu2,3,4, Feng Zhang5

  • 1Department of Pharmacy, Zhongshan Hospital, Fudan University, Shanghai, China.

Insights

This study identifies four key ion channels linked to hypertrophic cardiomyopathy (HCM) progression. These channels are associated with cardiac hypertrophy, fibrosis, and inflammation, offering potential diagnostic markers for HCM.

Area of Science:

  • Cardiovascular Genetics
  • Molecular Biology
  • Transcriptomics

Background:

  • Hypertrophic cardiomyopathy (HCM) is a common genetic heart condition.
  • Ion channel dysfunction is implicated in HCM development.
  • The precise link between HCM and specific ion channels requires further clarification.

Purpose of the Study:

  • To identify differentially expressed ion channels (DEICs) in HCM.
  • To explore the association between DEICs and pathological features of HCM.
  • To develop a prognostic model for HCM diagnosis based on DEICs.

Main Methods:

  • Comparative transcriptomic analysis across three datasets.
  • Clustering and enrichment analysis to identify hub DEICs.
  • Single-cell and spatial transcriptomic sequencing for expression analysis.
  • Prognostic model construction and immunoinfiltration analysis.
  • Validation in a mouse model of transverse aortic constriction (TAC).

Main Results:

  • Four hub DEICs (KCNC4, KCNN3, ANO1, CACNA2D3) were identified.
  • DEIC expression correlated significantly with myocardial hypertrophy, fibrosis, and fibroblast activation.
  • These genes are primarily expressed in cardiomyocytes and linked to fibrotic regions.
  • A prognostic model based on these DEICs demonstrated significant diagnostic value for HCM.
  • DEIC expression was associated with macrophage infiltration and cardiac inflammation.

Conclusions:

  • Integrative transcriptomic analysis identified four key ion channels associated with HCM development.
  • These ion channels are mechanistically linked to myocardial hypertrophy, fibrosis, and inflammatory changes in HCM.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Ion Channels01:19

Ion Channels

The movement of ions like sodium, potassium, and calcium into and out of the cell is essential to maintain the electrochemical gradient in living cells. The ion channels—a class of membrane transport proteins—help maintain this ionic gradient for the smooth functioning of physiological activities such as maintaining cell size and volume, conducting nerve impulses, and gas and nutrient exchange.
Ion channels are specialized integral membrane proteins on the plasma membrane that allow specific...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...